Introduction. In view of the continuing development of vaccines for various diseases, there is a need not only to keep health professionals informed, but also to understand how they perceive the risks of certain diseases for certain groups of patients. It is particularly important to identify how the perception of immunizations by both the medical profession and the direct beneficiaries, the patients, can be influenced. Materials and method. The study was based on a survey of 42 family physicians attending a symposium on the management of patients with Streptococcus pneumoniae infection. Data had been collected from participants before they heard the lectures at the event. Results. The information gathered from the survey revealed that doctors consider it useful for the health system to support immunization programs in order to increase immunization rates. It also revealed that the way one vaccination campaign is carried out can influence another, and that the doctor has a significant role in influencing the patient’s immunization. Conclusions. The success of vaccination campaigns in ensuring a good immunization rate depends on a good correlation between the involvement of the health system through the national immunization program, the health insurance system and the work of doctors who can significantly influence the patient’s decision to be vaccinated.
{"title":"Management of prophylaxis in Streptococcus pneumoniae infection","authors":"Ioana-Maria Bloj, Emese Orban, Edith-Simona Ianoşi, Remus Şipoş","doi":"10.26416/med.154.4.2023.8710","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8710","url":null,"abstract":"Introduction. In view of the continuing development of vaccines for various diseases, there is a need not only to keep health professionals informed, but also to understand how they perceive the risks of certain diseases for certain groups of patients. It is particularly important to identify how the perception of immunizations by both the medical profession and the direct beneficiaries, the patients, can be influenced. Materials and method. The study was based on a survey of 42 family physicians attending a symposium on the management of patients with Streptococcus pneumoniae infection. Data had been collected from participants before they heard the lectures at the event. Results. The information gathered from the survey revealed that doctors consider it useful for the health system to support immunization programs in order to increase immunization rates. It also revealed that the way one vaccination campaign is carried out can influence another, and that the doctor has a significant role in influencing the patient’s immunization. Conclusions. The success of vaccination campaigns in ensuring a good immunization rate depends on a good correlation between the involvement of the health system through the national immunization program, the health insurance system and the work of doctors who can significantly influence the patient’s decision to be vaccinated.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8714
Mihaela Udrescu
Romania is one of the European countries with a high prevalence of hepatitis viruses B, C and D infections. The World Health Organization objective is to eradicate the chronic infections with hepatitis viruses B, C and D until 2030. The eradication of these infections is possible only if all people infected with B, C or D hepatitis viruses are identified, all of them are correctly treated and monitored, and their contacts are tested, treated or vaccinated. This is a very strong issue, theoretically possible, but in the current practice, it is need for realistic objectives. LIVERO 2 is an important pilot project for the screening of viral hepatitis B, C and D, addressed to vulnerable people (more than 50% of tested people are mandatory from vulnerable categories). Family doctors had an important contribution in this project, the majority of the subjects being tested in their medical offices.
{"title":"Family doctor, an important element in the pilot project for the screening of chronic viral hepatitis B/C/D (LIVERO 2)","authors":"Mihaela Udrescu","doi":"10.26416/med.154.4.2023.8714","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8714","url":null,"abstract":"Romania is one of the European countries with a high prevalence of hepatitis viruses B, C and D infections. The World Health Organization objective is to eradicate the chronic infections with hepatitis viruses B, C and D until 2030. The eradication of these infections is possible only if all people infected with B, C or D hepatitis viruses are identified, all of them are correctly treated and monitored, and their contacts are tested, treated or vaccinated. This is a very strong issue, theoretically possible, but in the current practice, it is need for realistic objectives. LIVERO 2 is an important pilot project for the screening of viral hepatitis B, C and D, addressed to vulnerable people (more than 50% of tested people are mandatory from vulnerable categories). Family doctors had an important contribution in this project, the majority of the subjects being tested in their medical offices.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134889454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8711
Vasilica Ungureanu
Otitis media (OM) remains a major cause of morbidity worldwide, representing one of the complications of upper respiratory tract (URT) infections, especially in small children. The etiology of acute otitis media (AOM) can be viral, bacterial, viral-bacterial or bacterial-bacterial coinfections. The most common bacterial agents causing otitis media are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Viruses that can cause URT infections (respiratory syncytial virus, coronaviruses, influenza viruses, adenoviruses etc.) are increasingly recognized as contributors to the polymicrobial pathogenesis of otitis media. Other bacterial agents (Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa) have been rarely detected. Regarding the pathogenesis of AOM, multiple mechanisms contributing to the synergistic relationship between URT viruses and primary bacterial pathogens of otitis media have been identified and, although each of them has a specific effect, they all fall into the general category of compromising the host’s immune function and respiratory tract defense. An initial viral infection of the URT is necessary, which induces inflammation at this level and in the Eustachian tube, promoting bacterial superinfection of the middle ear. Preventing viral and bacterial infections of the upper respiratory tract infections associated with acute otitis media could reduce the incidence of middle ear infections in childhood.
中耳炎(OM)仍然是世界范围内发病率的主要原因之一，是上呼吸道感染的并发症之一，特别是在幼儿中。急性中耳炎(AOM)的病因可以是病毒、细菌-病毒、病毒-细菌或细菌-细菌共感染。引起中耳炎的最常见细菌是肺炎链球菌、流感弧菌和卡他莫拉菌。可引起上呼吸道感染的病毒(呼吸道合胞病毒、co - na - vi-rus病毒、流感病毒、腺病毒等)越来越多地被认为是中耳炎多微生物发病机制的贡献者。其他细菌制剂(链球菌-化脓球菌，金黄色葡萄球菌，铜绿假球菌)很少被检测到。在AOM的致病机制方面，目前已确定了多种机制来促进URT病毒与中耳炎媒介的原发细菌病原体之间的协同关系，虽然每种机制都有特定的作用，但都属于共同促进宿主免疫功能和免疫通道防御的一般模式。上呼吸道最初的病毒感染是新生的，它会引起上呼吸道和输卵管的炎症，促进中耳和中耳的细菌重复感染。预防与急性中耳炎相关的上呼吸道感染的病毒和细菌感染可以降低儿童中耳感染的发生率。
{"title":"Aspects of acute otitis media etiology and pathogenesis","authors":"Vasilica Ungureanu","doi":"10.26416/med.154.4.2023.8711","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8711","url":null,"abstract":"Otitis media (OM) remains a major cause of morbidity worldwide, representing one of the complications of upper respiratory tract (URT) infections, especially in small children. The etiology of acute otitis media (AOM) can be viral, bacterial, viral-bacterial or bacterial-bacterial coinfections. The most common bacterial agents causing otitis media are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Viruses that can cause URT infections (respiratory syncytial virus, coronaviruses, influenza viruses, adenoviruses etc.) are increasingly recognized as contributors to the polymicrobial pathogenesis of otitis media. Other bacterial agents (Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa) have been rarely detected. Regarding the pathogenesis of AOM, multiple mechanisms contributing to the synergistic relationship between URT viruses and primary bacterial pathogens of otitis media have been identified and, although each of them has a specific effect, they all fall into the general category of compromising the host’s immune function and respiratory tract defense. An initial viral infection of the URT is necessary, which induces inflammation at this level and in the Eustachian tube, promoting bacterial superinfection of the middle ear. Preventing viral and bacterial infections of the upper respiratory tract infections associated with acute otitis media could reduce the incidence of middle ear infections in childhood.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8715
Mihaela Paraschiv, Mihnea-Lucian Paraschiv
Background. Colorectal cancer is one of the malignancies that are diagnosed late and occupies the first places among the causes of death in Romania and worldwide. In the current study, we pointed out the major role of family medicine in the prevention and early detection of colorectal cancer through screening programs, such as ROCCAS II South-Muntenia project. Materials and method. For this retrospective study, a group of 411 people participated in a colorectal screening program, ROCCAS II Sud-Muntenia, between November 2021 and June 2023. Only people between 50 and 74 years old, who lived in South-Muntenia area, were included. The exclusion criteria were patients younger than 49 years old and over 75, and the residence in any other region of the country. Results. In this study, there were included 411 people, and 39 of them (9.48%) were identified with a high risk or with a very high risk of colorectal cancer. Out of the 24 people who accepted to proceed with colonoscopy, one person (4.24%) had colorectal cancer, 15 people (62.5%) had a precancerous lesion, and eight subjects (33.3%) had no lesion. Conclusions. Overall, in this study, the colorectal screening program ROCCAS II South-Muntenia proved its benefits for those individuals at risk, and managed to prevent lesions that could evolve into cancer in the following years for 5.48% of the subjects at risk.
背景。结直肠癌是诊断较晚的恶性肿瘤之一，在罗马尼亚和全世界的死亡原因中居首位。在本研究中，我们通过筛查项目，如ROCCAS II South-Muntenia项目，指出家庭疫苗在预防和早期发现结直肠癌方面的主要作用。材料和方法。在这项回顾性研究中，一组411人参加了2021年11月至2023年6月期间的结肠直肠癌筛查项目ROCCAS II Sud-Muntenia。只有居住在muntenia南部地区的50至74岁的人被包括在内。排除标准为年龄小于49岁，年龄大于75岁，居住在国内任何其他地区的患者。Re-sults。本研究纳入了411人，其中39人(9.48%)被确定为结直肠癌的高风险或极高风险。在接受结肠镜检查的24人中，1人(4.24%)患有合并直肠癌，15人(62.5%)有癌前病变，8人(33.3%)没有病变。Con-clu-sions。总体而言，在本研究中，南muntenia结肠直肠癌筛查项目ROCCAS II证明了其对高危人群的益处，并成功预防了5.48%的高危人群在接下来的几年中可能演变为癌症的病变。
{"title":"ROCCAS II South-Muntenia – model of good practice in general practitioner office","authors":"Mihaela Paraschiv, Mihnea-Lucian Paraschiv","doi":"10.26416/med.154.4.2023.8715","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8715","url":null,"abstract":"Background. Colorectal cancer is one of the malignancies that are diagnosed late and occupies the first places among the causes of death in Romania and worldwide. In the current study, we pointed out the major role of family medicine in the prevention and early detection of colorectal cancer through screening programs, such as ROCCAS II South-Muntenia project. Materials and method. For this retrospective study, a group of 411 people participated in a colorectal screening program, ROCCAS II Sud-Muntenia, between November 2021 and June 2023. Only people between 50 and 74 years old, who lived in South-Muntenia area, were included. The exclusion criteria were patients younger than 49 years old and over 75, and the residence in any other region of the country. Results. In this study, there were included 411 people, and 39 of them (9.48%) were identified with a high risk or with a very high risk of colorectal cancer. Out of the 24 people who accepted to proceed with colonoscopy, one person (4.24%) had colorectal cancer, 15 people (62.5%) had a precancerous lesion, and eight subjects (33.3%) had no lesion. Conclusions. Overall, in this study, the colorectal screening program ROCCAS II South-Muntenia proved its benefits for those individuals at risk, and managed to prevent lesions that could evolve into cancer in the following years for 5.48% of the subjects at risk.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8713
Daniela-Ligia Moşneagă
Coffee has a long way from cultivation to use, and a history of thousands of years. Its qualities were initially attributed to caffeine, but research has identified multiple bioactive compounds with health effects. Clinical studies seek answers to questions related to the effects on longevity, metabolism, cardiovascular, gastrointestinal, neuropsychological and cancer diseases. Future research is needed to recommend consumption and optimal quantity for preventive or curative purposes. This article reviews issues related to the history of coffee, its processing, chemical composition, relationship with gastrointestinal diseases and anticarcinogenic effects.
{"title":"Coffee – between story and clinical studies. About coffee, cancer and gastrointestinal diseases","authors":"Daniela-Ligia Moşneagă","doi":"10.26416/med.154.4.2023.8713","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8713","url":null,"abstract":"Coffee has a long way from cultivation to use, and a history of thousands of years. Its qualities were initially attributed to caffeine, but research has identified multiple bioactive compounds with health effects. Clinical studies seek answers to questions related to the effects on longevity, metabolism, cardiovascular, gastrointestinal, neuropsychological and cancer diseases. Future research is needed to recommend consumption and optimal quantity for preventive or curative purposes. This article reviews issues related to the history of coffee, its processing, chemical composition, relationship with gastrointestinal diseases and anticarcinogenic effects.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8709
Corina Eugenia Budin, Gabriela-Paula Pop
Bronchial asthma is characterized by chronic inflammation of the airways, associated with variable obstruction that limits air flow, and bronchial hyperactivity caused by various stimuli. The most common symptoms present in asthmatic people are wheezing, dyspnea, cough and chest constriction. Bronchial asthma has a high variability, which makes its phenotyping very important for guiding treatment. Among the most common phenotypes, we mention allergic asthma, nonallergic asthma, late-onset bronchial asthma, persistent asthma with a fixed limitation of airflow, and asthma associated with obesity. A thorough anamnesis and performing spirometry with bronchodilator test help us to establish the diagnosis of bronchial asthma. The increase in the maximum expiratory volume per second (VEMS) by 12% and 200 ml from the initial value after taking four short-acting bronchodilator puffs is suggestive of bronchial asthma. The ACT questionnaire is used to show whether the disease is well controlled therapeutically. Exposure to allergens, overweight, gastroesophageal reflux disease, rhinosinusitis, nasal polyposis and smoking are some of the comorbidities and triggers of bronchial asthma crisis. In terms of treatment, asthmatic patients have inhaled devices that contain as the first line of treatment inhaled corticosteroids to which a long-acting beta2-agonist is added. Choosing the right therapy for each patient is made on the basis of five stages of treatment, depending on the symptomatology of each individual patient, the phenotype of asthma and the comorbidities present. Patients with severe asthma benefit from targeted biological therapy.
支气管哮喘的特征是气道的慢性炎症，伴有限制空气流动的变异性阻塞，以及由各种刺激引起的支气管过度活跃。哮喘患者最常见的症状是喘息、呼吸困难、咳嗽和胸闷。支气管哮喘具有很高的变异性，这使得其表型对指导治疗非常重要。在最常见的表型中，我们提到过敏性哮喘、非过敏性哮喘、迟发性支气管哮喘、固定气流受限的持续性哮喘以及与肥胖相关的哮喘。彻底的记忆和支气管扩张试验的肺活量测定有助于我们确定支气管哮喘的诊断。服用四次短效支气管扩张剂后，最大每秒呼气量(VEMS)比初始值增加12%和200ml，提示支气管哮喘。ACT问卷用于显示疾病在治疗上是否得到良好控制。暴露于过敏原、超重、胃食管反流病、鼻窦炎、鼻腔息肉病和吸烟是支气管哮喘危象的一些合并症和诱发因素。在治疗方面，哮喘患者的吸入装置含有作为一线治疗的吸入co - ti - co - ste - roids，其中添加了长效β - 2激动剂。为每位患者选择合适的治疗方案是基于五个治疗阶段，这取决于每位患者的症状-病症-病症、哮喘的表型和存在的共病-病症。严重哮喘患者受益于靶向生物治疗。
{"title":"Interdisciplinary monitoring of the patient with bronchial asthma","authors":"Corina Eugenia Budin, Gabriela-Paula Pop","doi":"10.26416/med.154.4.2023.8709","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8709","url":null,"abstract":"Bronchial asthma is characterized by chronic inflammation of the airways, associated with variable obstruction that limits air flow, and bronchial hyperactivity caused by various stimuli. The most common symptoms present in asthmatic people are wheezing, dyspnea, cough and chest constriction. Bronchial asthma has a high variability, which makes its phenotyping very important for guiding treatment. Among the most common phenotypes, we mention allergic asthma, nonallergic asthma, late-onset bronchial asthma, persistent asthma with a fixed limitation of airflow, and asthma associated with obesity. A thorough anamnesis and performing spirometry with bronchodilator test help us to establish the diagnosis of bronchial asthma. The increase in the maximum expiratory volume per second (VEMS) by 12% and 200 ml from the initial value after taking four short-acting bronchodilator puffs is suggestive of bronchial asthma. The ACT questionnaire is used to show whether the disease is well controlled therapeutically. Exposure to allergens, overweight, gastroesophageal reflux disease, rhinosinusitis, nasal polyposis and smoking are some of the comorbidities and triggers of bronchial asthma crisis. In terms of treatment, asthmatic patients have inhaled devices that contain as the first line of treatment inhaled corticosteroids to which a long-acting beta2-agonist is added. Choosing the right therapy for each patient is made on the basis of five stages of treatment, depending on the symptomatology of each individual patient, the phenotype of asthma and the comorbidities present. Patients with severe asthma benefit from targeted biological therapy.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.26416/med.154.4.2023.8712
Remus Şipoş, Emese Orban
The establishment of the National Cancer Registry and its implementation as a computer and information system will help to understand the real burden of cancer diseases in Romania and could be the foundation on which to design, implement and run prevention programs. Its emergence is due to the rise in cancer incidence and mortality and represents the last step taken by the political decision-maker for the management of these pathologies. The need for clear records began to be formulated from a legislative point of view as early as 1980 when, by order of the Ministry of Health, reporting of these pathologies was made compulsory. Subsequently, in 2008, the establishment of Regional Cancer Registries began. According to the registered data, a report of the European Journal of Oncology highlighted the doubling of the number of deaths caused by cancer diseases in Romania in 2018, compared to 2009. The centralized data showed that prostate cancer ranked third when the incidence is analyzed in both sexes and second when the incidence analysis refers only to the male sex. The true extent of prostate cancer can only be determined by early and correct diagnosis. This involves presenting the patient to the doctor when symptoms appear which may be suggestive of potentially malignant prostate disease. Unfortunately, many information channels promote remedies that relieve such symptoms, remedies available both in pharmacies and through online orders, and this can delay the presentation to the doctor and, thus, the diagnosis.
国家癌症登记处的建立及其作为计算机和信息系统的实施将有助于了解罗马尼亚癌症疾病的真正负担，并可作为设计、实施和运行预防方案的基础。它的出现是由于癌症发病率和死亡率的上升，代表了政治决策者为管理这些病理所采取的最后一步。早在1980年，根据卫生部的命令，从立法角度开始制定明确记录的必要性，规定必须报告这些病症。随后，在2008年，开始建立区域癌症登记处。根据重新注册的数据，《欧洲肿瘤学杂志》(European Journal of oncology)的一份报告强调，2018年罗马尼亚因癌症导致的死亡人数比2009年翻了一番。集中数据显示，在男女发病率分析中，前列腺癌排在第三位，而在发病率分析中，仅指男性时，前列腺癌排在第二位。前列腺癌的真正程度只能通过早期和正确的诊断来确定。这包括当症状出现时将病人介绍给医生，这些症状可能暗示前列腺疾病可能是恶性的。不幸的是，许多医疗渠道都在宣传可以缓解这些症状的药物，这些药物在药店和在线订购中都有，这可能会延迟向医生提出，从而延误诊断。
{"title":"Optimizing the diagnosis of prostate malignancy","authors":"Remus Şipoş, Emese Orban","doi":"10.26416/med.154.4.2023.8712","DOIUrl":"https://doi.org/10.26416/med.154.4.2023.8712","url":null,"abstract":"The establishment of the National Cancer Registry and its implementation as a computer and information system will help to understand the real burden of cancer diseases in Romania and could be the foundation on which to design, implement and run prevention programs. Its emergence is due to the rise in cancer incidence and mortality and represents the last step taken by the political decision-maker for the management of these pathologies. The need for clear records began to be formulated from a legislative point of view as early as 1980 when, by order of the Ministry of Health, reporting of these pathologies was made compulsory. Subsequently, in 2008, the establishment of Regional Cancer Registries began. According to the registered data, a report of the European Journal of Oncology highlighted the doubling of the number of deaths caused by cancer diseases in Romania in 2018, compared to 2009. The centralized data showed that prostate cancer ranked third when the incidence is analyzed in both sexes and second when the incidence analysis refers only to the male sex. The true extent of prostate cancer can only be determined by early and correct diagnosis. This involves presenting the patient to the doctor when symptoms appear which may be suggestive of potentially malignant prostate disease. Unfortunately, many information channels promote remedies that relieve such symptoms, remedies available both in pharmacies and through online orders, and this can delay the presentation to the doctor and, thus, the diagnosis.","PeriodicalId":489459,"journal":{"name":"Medic.ro","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134888976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：